Shaoyan Liu
Overview
Explore the profile of Shaoyan Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
146
Citations
948
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Y, Liao L, Yan D, Liu J, Liu W, Liu S, et al.
Thyroid Res
. 2025 Mar;
18(1):6.
PMID: 40033421
Background: Age is an independent risk factor for central lymph node metastasis (CLNM) in clinically negative lymph node (cN0) papillary thyroid microcarcinoma (PTMC) patients. The objective of this study was...
2.
Song Y, Ning Y, Li H, He Y, Liu Y, Liu S
J Otolaryngol Head Neck Surg
. 2025 Feb;
54:19160216251314750.
PMID: 39945284
Objectives: The recurrence rate of T4a papillary thyroid cancer (PTC) is relatively high, but research on the prognosis of T4a PTC is rarely investigated. This study aims to analyze the...
3.
4.
Shi X, Tang H, Zhang T, Wang Y, Shen C, Zhang Y, et al.
EClinicalMedicine
. 2024 Nov;
77:102912.
PMID: 39534024
Background: Over 500,000 new cases are diagnosed with papillary thyroid cancer (PTC) globally per year, of whom the vast majority are in the low-risk stratification. Although thyroid-stimulating hormone (TSH) suppression...
5.
Kong Z, Li Z, Cui X, Wang J, Xu M, Liu Y, et al.
Cancer Discov
. 2024 Oct;
15(2):316-328.
PMID: 39470165
Medullary thyroid carcinoma (MTC) can only be cured through the excision of all metastatic lesions, but current clinical practice fails to localize the disease in 29% to 60% of patients....
6.
Xiong Z, Liu K, Liu S, Feng J, Wang J, Feng Z, et al.
BMC Cancer
. 2024 Sep;
24(1):1204.
PMID: 39350085
Background: With the development of novel anti-HER2 targeted drugs, such as ADCs, it has become increasingly important to accurately interpret HER2 expression in breast cancer. Previous studies have demonstrated high...
7.
Song Y, He Y, Kong Z, Peng B, Li H, Ning Y, et al.
World J Surg Oncol
. 2024 Sep;
22(1):249.
PMID: 39267073
Purpose: The survival rate of patients with medullary thyroid carcinoma (MTC) who fail to achieve a biochemical cure after surgery is reduced. This study aimed to investigate the prognostic factors...
8.
Liu Y, Song Y, He Y, Kong Z, Li H, Zhu Y, et al.
Endocrine
. 2024 Sep;
87(2):648-657.
PMID: 39266883
Objective: This study aimed to investigate the clinical characteristics and risk factors associated with the disease progression of T4a papillary thyroid carcinoma (PTC). Methods: In all, 602 patients (230 males;...
9.
Huang H, Liu Y, Yan D, Liu W, Liu S
Eur J Surg Oncol
. 2024 Aug;
50(11):108626.
PMID: 39213698
Purpose: Age is a significant predictor of papillary thyroid carcinoma (PTC). At present, the available evidence shows that age at diagnosis has an important impact on the recurrence of PTC....
10.
Lin S, Wang S, Jiang Q, Liu S, Liu S, Cai T
Respir Res
. 2024 Aug;
25(1):294.
PMID: 39095732
Background: Lianhuaqingwen (LHQW) has been used in the treatment of chronic bronchitis, but the precise mechanism through which LHQW exhibits its anti-inflammatory effects in this context is not yet fully...